摘要 |
Disclosed herein are methods for decreasing Factor 12 and treating or preventing thromboembolic conditions in an individual in need thereof. Examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to Factor 12 include thrombosis, embolism, and thromboembolism, such as, deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke, and mesenteric thrombosis. Methods for inhibiting Factor 12 can also be used as a prophylactic treatment to prevent individuals at risk for thrombosis and embolism. |
申请人 |
ISIS PHARMACEUTICALS, INC.;MONIA, BRETT, P.;MACLEOD, ROBERT, A.;CROSBY, JEFFREY, R. |
发明人 |
MONIA, BRETT, P.;MACLEOD, ROBERT, A.;CROSBY, JEFFREY, R. |